Depot antipsychotic drugs: place in therapy

JM Davis, L Metalon, MD Watanabe, L Blake - Drugs, 1994 - Springer
The pharmacokinetics of depot antipsychotic medications are such that an intramuscular
injection given at intervals of from 1 to 4 weeks will produce adequate plasma concentrations …

Clozapine: an atypical antipsychotic agent.

L Ereshefsky, MD Watanabe, TK Tran-Johnson - Clinical pharmacy, 1989 - europepmc.org
The pharmacology, pharmacokinetics, clinical efficacy, adverse effects, dosage, and cost of
the atypical antipsychotic drug clozapine are reviewed. Clozapine is a dibenzazepine …

Successful methylphenidate treatment of apathy after subcortical infarcts.

MD Watanabe, EM Martin, OA DeLeon… - The Journal of …, 1995 - europepmc.org
A patient with prominent apathy secondary to multiple subcortical infarcts was treated
successfully with methylphenidate. SPECT and reaction time testing showed selective …

Thiothixene pharmacokinetic interactions: a study of hepatic enzyme inducers, clearance inhibitors, and demographic variables

L Ereshefsky, SR Saklad, MD Watanabe… - Journal of clinical …, 1991 - journals.lww.com
Fifty-nine plasma thiothixene concentrations were measured in 42 patients as part of routine
therapeutic drug monitoring. Data collection included concomitant medications, smoking …

Pathophysiologic basis for schizophrenia and the efficacy of antipsychotics.

L Ereshefsky, TK Tran-Johnson, MD Watanabe - Clinical pharmacy, 1990 - europepmc.org
Current concepts of schizophrenia and its treatment are discussed. Schizophrenia entails
negative symptoms, such as behavioral and cognitive deficits, attributed to loss of normal …

Acute dietary tryptophan depletion: effects on schizophrenic positive and negative symptoms

…, LE Shapiro, SK Kamath, EA Soll, MD Watanabe… - …, 1997 - karger.com
Because brain serotonin levels depend directly on the amounts of exogenous tryptophan (TRP)
available for its synthesis, amounts of TRP in the diet may be manipulated to alter the …

Giants of orthopaedic surgery: Masaki Watanabe MD

M DeMaio - Clinical Orthopaedics and Related Research®, 2013 - journals.lww.com
… He read in a journal that Watanabe performed an arthroscopy [ 9 ]. To learn the … Watanabe
would be happy to see the application of endoscopy. For his contributions, I believe Watanabe

[HTML][HTML] Erythropoietin as a retinal angiogenic factor in proliferative diabetic retinopathy

D Watanabe, K Suzuma, S Matsui… - … England Journal of …, 2005 - Mass Medical Soc
Background Although vascular endothelial growth factor (VEGF) is a primary mediator of
retinal angiogenesis, VEGF inhibition alone is insufficient to prevent retinal neovascularization. …

Free radical pathways in the in vitro hepatic metabolism of phenelzine.

PRO de Montellano, MD Watanabe - Molecular pharmacology, 1987 - ASPET
The in vitro metabolism of phenelzine (2-phenylethylhydrazine) by phenobarbital-pretreated
rat liver microsomes yields ethylbenzene, 2-phenylethanol, 2-phenylacetaldehyde, …

Overview of depression and its management in children and adolescents.

K Lenz, K Coderre, MD Watanabe - Formulary, 2009 - search.ebscohost.com
Recently there has been an increase in the diagnosis of major depressive disorder (MDD)
in schoolaged chiidren and adolescents. MDD can be triggered by multiple Stressors and …